nCino NCNO 深 沪
等待开盘 12-19 09:30:00 美东时间
25.44
+0.050
+0.20%
华盛通- 最 高25.81
- 今 开25.51
- 成交量 44.86万股
- 最 低 25.255
- 昨 收 25.39
- 总市值 29.51亿
- 52周最高 35.43
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 18.7501
- 委 比 -86.96%
- 总股本 1.16亿
- 历史最高 103.95
- 量 比 0.53
- 振 幅 2.19%
- 历史最低 18.7501
- 每 手 1
- 风险率 3.48%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BTIG Initiates Coverage On Ncino with Neutral Rating
BTIG analyst Nick Altmann initiates coverage on Ncino (NASDAQ:NCNO) with a Neutral rating.
12-17 19:54
Shares of companies within the broader technology sector are trading lower amid weakness in Broadcom after it issued cautious outlook. The sector is also being weighed down by reports that Oracle delayed some data center projects for OpenAI.
Shares of companies within the broader technology sector are trading lower amid...
12-13 04:20
nCino sets $100M stock repurchase program
nCino (NCNO) board has authorized a stock repurchase program under which the company may repurchase up to $100M of its outstanding common stock. The company currently expects to fund the repurchase pr...
12-08 21:08
nCino Announces Stock Repurchase Program
nCino's Board authorizes a $100M stock buyback program, reflecting confidence in the company's strategy. Repurchases may occur via open market, block trades, or private transactions. Funding will come from existing cash and future cash flows. nCino offers intelligent banking solutions to over 2,700 global customers.
12-08 13:00
美股大行评级 | 潜在涨幅218.88%！Kyverna Therapeutics获摩根士丹利升目标价至25美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持Kyverna Therapeutics"超配"评级，目标价从20美元升至25美元；Maxim Group：维持Capricor Therapeutics"买入"评级，目标价从25美元升至50美元
12-05 08:35
Needham Reiterates Buy on Ncino, Maintains $38 Price Target
Needham analyst Mayank Tandon reiterates Ncino (NASDAQ:NCNO) with a Buy and maintains $38 price target.
12-05 00:19
nCino shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 adjusted EPS guidance above estimates. Also, the company raised its FY26 guidance above estimates.
nCino shares are trading higher after the company reported better-than-expected...
12-04 05:32
Ncino Raises FY2026 Adj EPS Guidance from $0.77-$0.80 to $0.90-$0.91 vs $0.79 Est; Raises FY2026 Sales Guidance from $585.000M-$589.000M to $591.900M-$593.400M vs $587.749M Est
Ncino (NASDAQ:NCNO) raises FY2026 Adj EPS guidance from $0.77-$0.80 to $0.90-$0.91 vs $0.79 analyst estimate. Raises FY2026 sales outlook from $585.000 million-$589.000 million to $591.900 million-$593.400 million vs
12-04 05:07
nCino Appoints Two New Independent Board Members
nCino announced the appointment of Andy Yasutake and Diego Dugatkin to its Board of Directors, bringing expertise in AI and product innovation. Yasutake, a veteran in AI and strategic growth, and Dugatkin, an experienced CPO specializing in AI-driven product development, will strengthen nCino's leadership in intelligent banking solutions. Their additions enhance the board's technical capabilities, supporting the company's growth and innovation. J...
12-03 21:01
Earnings Scheduled For December 3, 2025
Companies Reporting Before The Bell • Yuanbao (NASDAQ:YB) is likely to report e...
12-03 19:11
